Skip to main content
Filter By
Hearing
HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments
Letter
Letter to Chairman Cummings urging release of nonpublic memorandum of understanding with financial services chairwoman maxine waters
Hearing
DOD Inspector General Report on Excess Profits by TransDigm Group, Inc.
Press Release
Jordan Urges Cummings to Publicly Release Secret MOU Coordinating Democrat Attacks on the President

WASHINGTON, DC - Today, Representative Jim Jordan (R-OH), Ranking Member of the Committee on Oversight and Reform, sent a letter to Chairman Elijah Cummings (D-MD) urging him publicly release the nonpublic Memorandum of Understanding (MOU) he executed with Financial Services Chairwoman Maxine Waters as part of a coordinated and carefully ...
Post
The census fearmongering must end

By: Rep. Jim Jordan From: The Washington Post In his April 26 Friday Opinion essay, “The Supreme ...
Press Release
Ranking Member Jordan and Rep. Green Joint Statement on House Democrats’ Refusal to Hold Michael Cohen Accountable

WASHINGTON, D.C. - Today, the House of Representatives voted to not consider House Resolution 304, a resolution that would force House Democrats to hold convicted liar Michael Cohen accountable for his lies to the Committee. The resolution would require Chairman Elijah Cummings to transmit an official transcript of Cohen's testimony to the Justice Department for potential prosecution. Ranking Member Jim Jordan (R-OH) and Rep. Mark Green (R-TN) released the following statement ...
Post
Rep. Green Introduces House Resolution 304
Hearing
The Financial Condition of the Postal Service
Letter
Jordan Asks Waters if She Will Receive Mazars Documents from Cummings as Part of Democrats’ Coordinated Investigations
Post
Ranking Member Jim Jordan: Chairman Cummings is wrongly wielding his committee power to hurt private businesses

From The Plain Dealer April 23, 2019 A few weeks ago, U.S. House Oversight Committee Chairman Elijah Cummings boasted that his investigations negatively affected the stock prices of pharmaceutical companies. Rep. Mark Meadows and I